Sale Alert!

Check out our latest deals! NEOPAR®

  Home > Equine Direct > EQ Vaccines > FR: Influenza & Rhinopneumonitis >

Calvenza-03 EIV/EHV
Calvenza-03 EIV/EHV
Calvenza-03 EIV/EHV

Calvenza-03 EIV/EHV provides protection from rhinopneumonitis respiratory disease caused by EHV-4 and EHV-1. Maximum influenza protection includes new strains Ohio/2003, Kentucky 2/95 and Newmarket 2/93. For initial vaccination, give 2 ml IM, followed by a 2nd dose IM in 3-4 weeks. Administer a third dose 3-4 weeks later either IM or intranasally. Revaccinate annually prior to anticipated exposure. Please allow 24-48 hours for single doses to ship.

Item# Item Name Our Price Qty Add
980-034437 Calvenza-03 EIV/EHV 10 dose tank
980-034436 Calvenza-03 EIV/EHV Single Dose
Check the items you wish to purchase, then click

Extended Information:

Calvenza®-03 EIV/EHV
Boehringer Ingelheim

Equine Rhinopneumonitis-Influenza Vaccine
Killed Virus

For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory diseases caused by equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4), and by equine influenza virus types A2 North American and A2 Eurasian.

Administration and Dosage:
Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 2 mL dose. Administer a second 2 mL dose intramuscularly in 3-4 weeks using a different injection site. Administer a third 2 mL dose in 3-4 weeks by either the intramuscular or intranasal route. Revaccinate annually and prior to anticipated exposure, by either the intramuscular or intranasal route.

For Veterinary Use Only

Store at 35-45°F (2-7°C). Protect from freezing. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.


Share your knowledge of this product with other customers... Be the first to write a review

Browse for more products in the same category as this item:

Equine Direct > EQ Vaccines > FR: Influenza & Rhinopneumonitis

Social Tab
Are you a fan of A to Z Vet Supply?
Hide Bar

Read our latest blog post...